| Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma J Dornbusch, A Zacharis, M Meinhardt, K Erdmann, I Wolff, M Froehner, ... PloS one 8 (9), e76386, 2013 | 75 | 2013 |
| Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma J Busch, C Seidel, S Weikert, I Wolff, C Kempkensteffen, L Weinkauf, ... BMC cancer 11, 1-5, 2011 | 65 | 2011 |
| Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients HA Meyer, T Endermann, C Stephan, M Stoedter, T Behrends, I Wolff, ... Public Library of Science 7 (10), e46644, 2012 | 63 | 2012 |
| Sequence therapy in patients with metastatic renal cell carcinoma: comparison of common targeted treatment options following failure of receptor tyrosine kinase inhibitors J Busch, C Seidel, C Kempkensteffen, M Johannsen, I Wolff, S Hinz, ... European urology 60 (6), 1163-1170, 2011 | 61 | 2011 |
| Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer S Weikert, H Krause, I Wolff, F Christoph, M Schrader, T Emrich, K Miller, ... International journal of cancer 117 (2), 274-280, 2005 | 59 | 2005 |
| Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a … I Wolff, M May, B Hoschke, R Zigeuner, L Cindolo, G Hutterer, L Schips, ... European Journal of Surgical Oncology (EJSO) 42 (5), 744-750, 2016 | 57 | 2016 |
| Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1–pT3a localized renal cell carcinoma in a comprehensive multicenter study … SD Brookman-May, M May, I Wolff, R Zigeuner, GC Hutterer, L Cindolo, ... European urology 67 (5), 943-951, 2015 | 56 | 2015 |
| Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer OY Dokun, AR Florl, HH Seifert, I Wolff, WA Schulz International journal of cancer 123 (12), 2798-2807, 2008 | 55 | 2008 |
| Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease N Wagener, D Edelmann, A Benner, R Zigeuner, H Borgmann, I Wolff, ... Plos one 12 (9), e0184173, 2017 | 37 | 2017 |
| Retzius sparing radical prostatectomy versus robot-assisted radical prostatectomy: which technique is more beneficial for prostate cancer patients (MASTER Study)? A systematic … B Barakat, H Othman, U Gauger, I Wolff, B Hadaschik, C Rehme European Urology Focus 8 (4), 1060-1071, 2022 | 33 | 2022 |
| Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder F Christoph, S Weikert, I Wolff, M Schostak, K Tabiti, M Müller, K Miller, ... Cancer letters 245 (1-2), 121-126, 2007 | 32 | 2007 |
| Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke? I Wolff, S Brookman-May, M May Current opinion in urology 25 (5), 418-426, 2015 | 31 | 2015 |
| Advances in renal cell carcinoma treatment MO Grimm, I Wolff, S Zastrow, M Fröhner, M Wirth Therapeutic Advances in Urology 2 (1), 11-17, 2010 | 28 | 2010 |
| Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi … H Borgmann, M Musquera, A Haferkamp, A Vilaseca, T Klatte, SF Shariat, ... World Journal of Urology 35 (12), 1891-1897, 2017 | 25 | 2017 |
| Male circumcision is not associated with an increased prevalence of erectile dysfunction: results of the Cottbus 10,000-men survey B Hoschke, S Fenske, S Brookman-May, I Spivak, C Gilfrich, HM Fritsche, ... Der Urologe 52, 562-569, 2013 | 19 | 2013 |
| No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time F Friedersdorff, I Wolff, S Deger, J Roigas, J Buckendahl, H Cash, ... World journal of urology 29, 561-566, 2011 | 18 | 2011 |
| Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey FA Distler, S Pahernik, G Gakis, G Hutterer, S Lebentrau, M Rink, P Nuhn, ... World journal of urology 38, 2523-2530, 2020 | 14 | 2020 |
| Impact of surgeon’s experience on outcome parameters following ureterorenoscopic stone removal I Wolff, S Lebentrau, A Miernik, T Ecke, C Gilfrich, B Hoschke, M Schostak, ... Urolithiasis 47 (5), 473-479, 2019 | 14 | 2019 |
| Kidney cancer and chronic kidney disease: Too close for comfort PC Pinto, C Rönnau, M Burchardt, I Wolff Biomedicines 9 (12), 1761, 2021 | 11 | 2021 |
| Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer D Vergho, M Burger, M Schrammel, S Brookman-May, M Gierth, ... World Journal of Urology 33, 725-731, 2015 | 11 | 2015 |
